$15M Bet On Day One Biopharmaceuticals? Check Out These 3 Stocks Insiders Are Buying
$15M Bet On Day One Biopharmaceuticals? Check Out These 3 Stocks Insiders Are Buying
Although U.S. stocks closed lower on Friday, there were a few notable insider trades.
尽管美国股市周五收盘走低，但仍有一些值得注意的内幕交易。
When insiders purchase shares, it indicates their confidence in the company's prospects or that they view the stock as a bargain. Either way, this signals an opportunity to go long on the stock. Insider purchases should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a buying decision.
当内部人士购买股票时，这表明他们对公司的前景充满信心，或者他们认为这只股票很划算。无论哪种方式，这都标志着做多该股的机会。内幕收购不应被视为做出投资或交易决定的唯一指标。充其量，它可以让买入决定更有说服力。
Below is a look at a few recent notable insider purchases. For more, check out Benzinga's insider transactions platform.
以下是最近几笔值得注意的内幕交易。欲了解更多信息，请查看Benzinga的内幕交易站台。
Day One Biopharmaceuticals
生物制药的第一天
- The Trade: Day One Biopharmaceuticals, Inc. (NASDAQ:DAWN) 10% owner Len Blavatnik acquired a total of 1,475,454 shares an average price of $10.15. To acquire these shares, it cost around $14.98 million.
- What's Happening: Day One Biopharmaceuticals submitted rolling new drug application to the FDA for tovorafenib in relapsed or progressive pediatric low-grade glioma.
- What Day One Biopharmaceuticals Does: Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers.
- 行业： 第一天生物制药公司。(纳斯达克：黎明)10%的所有者Len Blavatnik共购入1,475,454股均价为10.15美元。收购这些股份的成本约为1498万美元。
- 正在发生的事情：第一天，生物制药公司向FDA提交了针对托伏拉非尼治疗复发或进展性儿童低级别胶质瘤的滚动新药申请。
- 第一天生物制药的用途：第一天生物制药公司是一家临床阶段的生物制药公司。它致力于为所有年龄段的基因定义癌症患者开发和商业化靶向治疗。
Central Securities
中央证券
- The Trade: Central Securities Corporation (NYSE:CET) Vice President Andrew J. O'Neill acquired a total of 1,954 shares at an average price of $35.80. To acquire these shares, it cost around $69,947.
- What's Happening: The company's stock gained around 6% year-to-date.
- What Central Securities Does: Central Securities Corp is a non-diversified closed-end management investment company. Its investment objective is long-term growth of capital.
- 行业： 中央证券公司(纽约证券交易所股票代码：CET)副总裁安德鲁·J·奥尼尔以35.8美元的平均价格收购了1,954股。收购这些股票的成本约为69,947美元。
- 正在发生的事情：今年到目前为止，该公司的股票上涨了约6%。
- 中央证券的业务：中央证券公司是一家非多元化封闭式管理投资公司。其投资目标是资本的长期增长。
Don't forget to check out our premarket coverage here
别忘了在这里查看我们的售前报道
RE/MAX Holdings
Re/Max Holdings
- The Trade: RE/MAX Holdings, Inc. (NYSE:RMAX) 10% owner Magnolia Group LLC bought a total of 15,000 shares at an average price of $10.74. To acquire these shares, it cost around $161,100.
- What's Happening: RE/MAX Hldgs posted in-line earnings for the second quarter.
- What RE/MAX Holdings Does: RE/MAX Holdings Inc operates as a franchisor of real estate brokerage services. It recruits and retains agents and sells franchises.
- 行业： Re/Max控股公司(纽约证券交易所代码：RMAX)10%的股东木兰花集团有限责任公司共买入15,000股均价为10.74美元。收购这些股票的成本约为161,100美元。
- 正在发生的事情：Re/Max Hldgs公布了第二季度的在线收益。
- RE/MAX控股公司的业务：Re/Max Holdings Inc.是房地产经纪服务的特许经营商。它招募和保留代理商，并销售特许经营权。
Check This Out: Top 4 Health Care Stocks That May Rocket Higher This Month
看看这个：4大医疗保健类股本月可能走高